Hematologic and Oncologic Diseases and the Liver

被引：13

作者：

Singh, Marvin M.

Pockros, Paul J. ^{[1
]}

机构：

[1] Scripps Clin Torrey Pines, Div Gastroenterol & Hepatol, La Jolla, CA 92037 USA

来源：

CLINICS IN LIVER DISEASE | 2011年 / 15卷 / 01期

关键词：

Hemolytic anemias; Malaria; Banti syndrome; Porphyrias; Leukemias; Hepatic metastases; DISSEMINATED INTRAVASCULAR COAGULATION; FULMINANT HEPATIC-FAILURE; BUDD-CHIARI-SYNDROME; BILE-DUCT SYNDROME; T-CELL LYMPHOMA; METASTATIC NEUROENDOCRINE TUMORS; ACUTE INTERMITTENT PORPHYRIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; SIDED PORTAL-HYPERTENSION; SINGLE-CENTER EXPERIENCE;

D O I：

10.1016/j.cld.2010.09.013

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Malignant and nonmalignant disorders may affect the liver, causing signs and symptoms ranging from mild increases of liver tests to fulminant hepatic failure. This article discusses the most common hematologic and oncologic disorders and their effect on the liver. The section on nonmalignant hematologic disorders includes the anemias, paroxysmal nocturnal hemoglobinuria, disseminated intravascular coagulation, malaria, Banti syndrome, the porphyrias, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. Malignant hematologic conditions include leukemias, lymphomas, and myeloproliferative disorders. Other conditions causing portal hypertension and hepatic metastases are also discussed. The most commonly encountered hepatic manifestations of hematologic and oncologic disorders are reviewed.

引用

页码：69 / +

页数：20

共 88 条

[81] Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis [J].